This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

D. Jackson Coleman, MD
New York

Arch Ophthalmol. 1985;103(8):1113.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Wilensky has described a complication in a patient referred to the New York Hospital/ Cornell Medical Center for therapeutic ultrasound treatment. In our recent article describing the initial clinical results of the ultrasound treatment on our first 42 patients with a minimum three-month follow-up, all complications and side effects noted at the time of manuscript preparation are discussed.¹ The clinical trial has continued, and to date over 160 patients have been treated. Our development of this new treatment modality has afforded us the unique opportunity to assess prognostic variables and risk factors in a purely prospective manner. Ongoing exploratory data analysis has identified three cases of visible scleral defects or staphylomas in adults. In the 16 patients aged 15 years or younger who were treated, visible scleral defects were noted in four (including Dr Wilensky's patient), and is related inversely to treatment efficacy. As the sample . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?